The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial "STOP-HARM"

Withdrawn

Phase 4 Results N/A

Summary of Purpose

Patients with severe chronic kidney disease (CKD) who develop atrial fibrillation are at high risk for stroke. The use of blood thinking medication in dialysis patients is controversial and warfarin carries a serious risk for major bleeding. The Watchman device may be an ideal therapy for this population as after... Trial Stopped: Failure to recruit any participants in more than one year of recruiting.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 March 2018.

1 Sep 2016 24 Jun 2016 5 Mar 2018 5 Mar 2018 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Intervention: Parallel Assignment

Contacts

  • Carlos Morillo, MD

  • Michael Walsh, MD